The angiotensin-converting enzyme genotype and microalbuminuria in autosomal dominant polycystic kidney disease

Journal of the American Society of Nephrology

Volumn 10, Issue 9, 1999, Pages 1916-1920

  Van Dijk, Marjan A ^a   Peters, Dorien J M ^b   Breuning, Martijn H ^b   Chang, Peter C ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; DNA; POTASSIUM ION; SODIUM ION;

ADULT; AGE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BLOOD PRESSURE MONITORING; BODY SURFACE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE DELETION; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN CELL; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MICROALBUMINURIA; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; SODIUM EXCRETION;

EID: 0032814576     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v1091916     Document Type: Article

References (46)

1. Kimberling WJ, Kumar S, Gabow PA, Kenyon JB, Connolly CJ, Somlo S: Autosomal dominant polycystic kidney disease: Localization of the second gene to chromosome 4q13-q23. Genomics 18: 467-472, 1993
2. Peters DJ, Spruit L, Saris JJ, Ravine D, Sandkuijl LA, Fossdal R, Boersma J, van Eijk R, Norby S, Constantinou-Deltas CD: Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease. Nat Genet 5: 359-362, 1993
3. Peters DJ, Sandkuijl LA: Genetic heterogeneity of polycystic kidney disease in Europe. Contrib Nephrol 97: 128-139, 1992
4. Turco AE, Clementi M, Rossetti S, Tenconi R, Pignatti PF: An Italian family with autosomal dominant polycystic kidney disease unlinked to either the pkd1 or pkd2 gene. Am J Kidney Dis 28: 759-761, 1996
5. Hateboer N, Van Dijk MA, Dogdanova N, Coto E, Saggar-Malik AK, San Millan JL, Torra R, Breuning MH, Ravine D: Comparison of phenotypes of polycystic kidney disease types 1 and 2. Lancet 353: 103-107, 1999
6. Gabow PA: Autosomal dominant polycystic kidney disease. Am J Kidney Dis 22: 511-512, 1993
7. Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH: Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 41: 1311-1319, 1992
8. Chapman AB, Johnson AM, Gabow PA, Schrier RW: Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5: 1349-1354, 1994
9. Choukroun G, Itakura Y, Albouze G, Christophe JL, Man NK, Grunfeld JP, Jungers P: Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 6: 1634-1642, 1995
10. Gonzalo A, Gallego A, Rivera M, Orte L, Ortuno J: Shape of the relationship between hypertension and the rate of progression of renal failure in autosomal dominant polycystic kidney disease. Nephron 62: 52-57, 1992
11. Gonzalo A, Gallego A, Rivera M, Orte L, Ortuno J: Influence of hypertension on early renal insufficiency in autosomal dominant polycystic kidney disease. Nephron 72: 225-230, 1996
12. Marcelli D, Locatelli F, Alberti D, Graziani G, Buccianti C, Redaelli B, Giangrande A: Hypertension as a factor in chronic renal insufficiency progression in polycystic kidney disease. Nephrol Dial Transplant 10: 15-17, 1995
13. Peral B, Ong ACM, San Millan JL, Gamble V, Rees L: A stable, nonsense mutation associated with a case of infantile onset polycystic kidney disease 1 (PKD1). Hum Mol Genet 5: 539-542, 1996
14. Milutinovic J, Rust PF, Fialkow PJ, Agodoa LY, Phillips LA, Rudd TG, Sutherland S: Intrafamilial phenotypic expression of autosomal dominant polycystic kidney disease. Am J Kidney Dis 19: 465-472, 1992
15. Barrett BJ, Foley R, Morgan J, Hefferton D, Parfrey P: Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members. Kidney Int 46: 1118-1123, 1994
16. Chapman AB, Johnson A, Gabow PA, Schrier RW: The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease [see comments]. N Engl J Med 323: 1091-1096, 1990
17. Torres VE, Wilson DM, Burnett J Jr, Johnson CM, Offord KP: Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease. Mayo Clin Proc 66: 1010-1017, 1991
18. Geberth S, Stier E, Zeier M, Mayer G, Rambausek M, Ritz E: More adverse renal prognosis of autosomal dominant polycystic kidney disease in families with primary hypertension. J Am Soc Nephrol 6: 1643-1648, 1995
19. Tiret L, Rigat B, Viskivis S, Brenda C, Corvol P, Cambien F, Soubrier F: Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) controls plasma ACE levels. Am J Hum Genet 51: 197-205, 1992
20. Harrap SB, Davidson HR, Conner JM, Soubrier F, Corvol P, Fraser R, Foy CJ, Watt GC: The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 21: 455-460, 1993
21. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Laouel J-M: Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet 1: 72-75, 1992
22. Ueda S, Elliott HL, Morton JJ, Connell J: Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 25: 1266-1269, 1995
23. Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, Cohen D, Passa P, Froquel P: Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 91: 3662-3665, 1994
24. Raynolds MV, Bristow MR, Bush E, Abraham WT, Lowes BD, Zisman LS, Taf CS, Perryman MB: Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 342: 1073-1075, 1993
25. Ukkola O, Savolainen MJ, Salmela PI, Vondickhoff K, Kiema T, Kesaniemi YA: Insertion/deletion polymorphism in the angiotensin-converting enzyme gene associated with macroangiopathy and blood pressure in patients with non-insulin-dependent diabetes mellitus. J Mol Med 73: 307-311, 1995
26. Moriyama T, Kitamura H, Ochi S, Izumi M, Yokoyama K, Yamauchi A, Ueda N, Kamada T, Imai E: Association of angiotensin I-converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I-converting enzyme inhibitors in patients with proteinuria. J Am Soc Nephrol 6: 1674-1678, 1995
27. Hofmann W, Guder WG: A diagnostic programme for quantitative analysis of proteinuria. J Clin Chem Clin Biochem 27: 589-600, 1989
28. Miller SA, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells [Abstract]. Nucleic Acids Res 16: 1215, 1988
29. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DPC1) (dipeptidyl carboxypeptidase) [Abstract]. Nucleic Acids Res 20: 1433, 1992
30. Shanmugam V, Sell KW, Saha BK: Mistyping ACE heterozygotes. PCR Methods Appl 3: 120-121, 1993
31. James MA, Fotherby MD, Potter JF: Screening test for microalbuminuria in non-diabetic elderly subjects and their relation to blood pressure. Clin Sci 88: 185-190, 1995
32. Schmidt S, Stier E, Hartung R, Stein G, Bahnisch J, Woodroffe AJ, Clarkson AR, Ponticelli C, Campise M, Mayer G, Ganten D, Ritz E: No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis. Am J Kidney Dis 26: 727-731, 1995
33. Yeh J: Albuminuria and cardiovascular disease risk factors in American Indians. Circulation 82: 620-630, 1990
34. Kario K, Kanai N, Nishiuma S, Fujii T, Saito K, Matsuo T, Matsuo M, Shimada K: Hypertensive nephropathy and the gene for angiotensin-converting enzyme. Arterioscler Thromb Vasc Biol 17: 252-256, 1997
35. Doi Y, Yoshizumi H, Yoshinari M, Iino K, Yamamoto M, Ichikawa K, Iwase M, Fujishima M: Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 39: 97-102, 1996
36. Battilana C, Zhang H, Olshen RA, Wexler L, Myers BD: PAH extraction and estimation of plasma flow in deceased human kidneys. Am Physiol Soc 261: F726-F733, 1991
37. Parving HH, Jensen HAE, Mogensen CE, Evrin PE: Increased urinary albumin excretion rate in benign essential hypertension. Lancet 1: 1190-1192, 1974
38. Ljungman S: Microalbuminuria in essential hypertension. Am J Hypertens 3: 956-960, 1990
39. Barley J, Blackwood A, Miller M, Markandu ND, Carter ND, Jeffery S, Cappuccio FP, Macgregor GA, Sagnella GA: Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples. J Hum Hypertens 10: 31-35, 1996
40. Lachurie ML, Azizi M, Guyene TT, Alhencgelas F, Menard J: Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation 91: 2933-2942, 1995
41. Fornage M, Amos CI, Kardia S, Sing CF, Turner ST, Boerwinkle E: Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation 97: 1773-1779, 1998
42. O'Donnell C, Lindpainter K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH, Levy D: Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham heart study. Circulation 97: 1766-1772, 1998
43. Danser AHJ, Koning MMG, Admiraal PJJ, Derkx FHM, Verdouw PD, Schalekamp MADH: Metabolism of angiotensin I by different tissues in the intact animal. Am J Physiol 263: H418-H428, 1992
44. Muller DN, Bohlender J, Hilgers KF, Dragun D, Costerousse O. Menard J, Luft FC: Vascular angiotensin-converting enzyme expression regulates local angiotensin II. Hypertension 29: 98-104, 1997
45. Uemasu J, Nakaoka A, Kawasaki H, Ishikawa I, Yoshino Y, Shio H, Nemoto R, Nakamura I, Morio S: Association between angiotensin converting enzyme gene polymorphism and clinical features in autosomal dominant polycystic kidney disease. Life Sci 60: 2139-2144, 1997
46. Baboolal K, Ravine D, Daniels J, Williams N, Holmans P, Coles GA, Williams JD: Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease. Kidney Int 52: 607-613, 1997